Post

Digital transformation of the supply chain will make data more valuable – are you prepared?

It has been a long decade for the pharmaceutical industry. Some changes, like the pace of innovation and influx of …

Immunocore and BMS partner to investigate first-line treatment for melanoma

Immunocore has signed a clinical trial collaboration and supply agreement with Bristol Myers Squibb (BMS) to develop its drug IMC-F106C …

Harmony wins orphan drug tag for pitolisant to treat Prader-Willi syndrome 

US-based biopharmaceutical company Harmony Biosciences has secured a US Food and Drug Administration (FDA) orphan drug designation for its drug …

Immune-Onc’s antibody therapy collects second FDA orphan designation

The US Food and Drug Administration (FDA) has granted an orphan drug designation to Immune-Onc Therapeutics’ IO-202 for the treatment …

United Therapeutics sues FDA over handling of Liquidia’s NDA

United Therapeutics has sued the US Food and Drug Administration (FDA), claiming the agency did not follow rules when approving …